Genflow Biosciences present at the UK Investor Magazine Investor Evening June 2022.

Genflow Biosciences are developing life-prolonging and longevity therapies for use in humans and animals. Their focus is on improving the quality of life while helping people live a fuller life. This presentation includes a delve into the science and the current state of the longevity and age-related market.

Download Presentation Slides Here

Previous articleSulNOx Investor Presentation
Next articleCaracal Gold Investor Presentation
This is the profile of the UK Investor Magazine team who, in collaboration with each other and our partners, produce a number of in-depth analytical articles, reviews of investment services and publish sponsored articles from carefully selected partners.